The Future is in Our Hands
Blog
Information, Awareness, Prevention / United to End Cancer

[This document is available in PDF at Google Drive “goo.gl/04HRq2” and in HTML at http://blog.u2ec.org/wordpress/?p=2004]

[The one page pitch to investigative journalists is available in PDF at goo.gl/9KzNJ6]

[The respectful request to Citigroup to address my concerns expressed in my letters is available in PDF at Google Drive “goo.gl/VtpNxL” and in HTML at http://blog.u2ec.org/wordpress/?p=2004]

Dear investigative journalists your professional assistance and help for millions of people dying needlessly and taxpayer having hundreds of millions of dollars wasted is urgently needed.Please read the nine paragraphs after the title in blue, in CAPITAL LETTERS (and the fine print reporting the essence and references of inventions that have been suppressed for two decades by influential scientists) summarizing the situation of innovations recognized valuable by academia, industries and research centers, at a major public, scientific, international review, endorsed by top experts in the field, published in a 45-page article by a prestigious scientific journal and proven feasible and functional in hardware.

 

Recently the 3D-Flow OPRA and 3D-CBS (3-D Complete Body Screening) inventions have been proven feasible with current technology by 59 quotes from reputable industries. The 3D-Flow OPRA can replace 4,000 CMS electronic data processing boards in physics experiments with 9 electronic data processing boards while providing an enormous performance improvement at one thousandth the cost. The 3D-CBS can claim to be the first true paradigm change in molecular imaging because it offers at once the three advantages of a) an effective early detection of diseases at a highly curable stage, improved diagnosis, prognosis and monitoring treatments effectively, b) a radiation dose that is 1% of current PET and c) a 4-minute, very low examination cost that will cover all organs of the body. Therefore, individual screening on specific parts of the body, such as mammograms, PAP-tests, colonoscopies and PSA, will not be necessary.

 

However, recently Citigroup agents, made me believe since April 17, 2017, that they were addressing my concerns that I submitted in several letters, instead, after making over 700 phone calls to my cell and home phone they have reported me to the credit bureau, destroyed my credit score that took me 26 years to build from 834 to 726 and now their agents have told me that on May 27, 2017, Citigroup will start a collection procedure that will remove my tools: table, chair, computers, oscilloscopes, Logic State Analyzer, etc., that will impede me to continue my research.  Citigroup, contributing more to destroy me personally with the collection, is on the path to repeat, 172 years later, the same scenario  Semmelweis experienced in 1847.  (See goo.gl/SA109k).

 

I urge the collaboration of all investigative journalists to demand influential scientists to organize a transparent, public, scientific review at CERN in Geneva, at the U.S. Department of Energy, at the National Institutes of Health, National Cancer Institute of my inventions similar to the 1993 FERMILAB scientific review that was requested by the Director of the Superconducting Super Collider (also Director of FERMILAB) for my previous invention, that was recognized valuable.


 

Investigative journalists your attention and help are needed by millions of people who are dying needlessly and by taxpayers whose hundreds of millions of dollars are being wasted

Millions of people are suffering and dying needlessly from the most deadly (8.2 Million/year) and costly ($1.4 Trillion/year) calamity, cancer, while a solution for its detection at an early curable stage has existed for 17 years.  A few influential scientists working at the most expensive experiment in the history of the planet at CERN are suppressing innovations and wasting hundreds of millions of taxpayer dollars. These need investigating!

There is solid proof that over 50% of cancer deaths can be avoided with early detection as there are many treatment options when cancer is detected early and most have great success. Treatments, however, do not work when detected in cancer’s later stages. Take for example colon cancer: If caught early it has a 91% survival rate, versus 11% if caught too late. Breast cancer has a 98% survival rate when detected at an early stage and 27% when detected late. What is missing is a non-invasive diagnostic device effective for early cancer detection.

A solution providing effective early cancer detection has existed for 17 years. It is the 3D-CBS (3-D Complete Body Screening) life-saving technology based on the 3D-Flow OPRA invention. I can help investigative journalists working for this cause to inform them and the public, but I do not have your experience and your connections to the public.

We cannot let the public down on these two important issues.  You should give them a high priority because of the number of lives they affect and who will benefit. (Please ask to sign the Petition at: goo.gl/dzmYCz)

There is no need for you, investigative journalists, to be expert in physics, biology or medical imaging (although having some knowledge and understanding of science will help); what is needed is the courage to seek and reveal the truth.

      You need to ask the right questions to uncover the truth. I can help carve the questions, whose answers from decision-makers will uncover the truth: Questions that refer to violations of laws, rules, and procedures, which are damaging to taxpayers and cancer patients, and are contradictory to science.

You can publish weekly questions from the public and my answers, and your connection to the people would have the power to influence the decision-makers who hold positions of responsibility in the field, so they provide the public with answers. Here are examples of articles published every week in English and Italian goo.gl/XnF3JR; however, the audience for these newspapers is very limited and the questions for the people holding responsibilities in the field are ignored.

For example, I answered (goo.gl/IkXrEm) Joel Butler’s Feb. 28, 2017, request regarding my peer-reviewed 45-page article published by one of the most prestigious scientific journals, but he did not answer my question on whether he could provide the reference to any approach/project proving analytically to be more cost-effective than my 3D-Flow OPRA, nor did he state why he is not following the invitation from CERN Director General to organize a discussion/review at CERN with experts.

On May 15, 2017, I provided very compelling arguments in my letters “goo.gl/7a9nSK” and “goo.gl/hea4EC” to the leaders in the field. The following day, I called Joel Butler, Nadia Pastrone at CERN, but they stated they do not intend to address the issues in the letters, while Andy Lankford at CERN and Jim Siegrist at U.S. DOE did not respond.

There is an urgent need for investigative journalists working in the public interest to inform the public at large and get their support to ensure decision-makers address the wastage of hundreds of millions of tax-dollars and the millions of lives needlessly lost to avoid repeating the same mistake which occurred in 1847 with Semmelweis “goo.gl/SA109k”.

Please respond to Dario Crosetto (goo.gl/VXBx33), 900 Hideaway Place, DeSoto, TX 75115. Email: crosettodario@gmail.com

What is missing is a non-invasive diagnostic device, effective for early cancer detection in all organs of the body that can capture the most relevant and reliable signals related to the mutation of the very first normal cells into cancerous cells. Among the change in odor, temperature, conductivity, fluorescence, density, metabolism etc. of normal cells into cancerous cells, the most reliable signal is the one related to a change in metabolism. Cancerous cells eat from 5 to 70 times more nutrient than normal cells because they grow faster than normal cells -the more aggressive the tumor is, the more nutrient it eats. The technique to track the nutrient delivered by the blood stream to the trillion cells in our body is called Positron Emission Technology (PET). It works by tagging the molecules of the nutrient to the body cells such as oxygen, glucose etc. with a radioisotope (radiation) that is emitting two 511 keV photons in opposite direction with an energy that can pass through flesh and bones and exit the body of the patient. The PET technique was invented in 1953 and today we have over 10,000 PET devices in use in hospitals. However, these PET devices are not useful for early detection because of their inefficiency of capturing only about 1 out of 10,000 pairs of good photons, requiring a high radiation dose to the patient. Because the basic technology is related to the efficiency in detecting specific subatomic particles among a huge number of signals received from the radiation, the breakthrough must come from the field of particle physics and should be in the Level-1 Trigger unit (or “The Trap”). My 3D-Flow invention that breaks the speed barrier in real-time application provides this breakthrough and has been recognized as valuable by academia, industries and research centers at a major public, scientific, international review (goo.gl/zP76Tc), endorsed by top experts in the field (goo.gl/GIC5aR and goo.gl/VXBx33), published in a 45-page article by a prestigious scientific journal (goo.gl/BlSzQu), and proven feasible and functional in hardware (goo.gl/RiIn0B). The 3D-Flow provides unprecedented advantages in capturing all possible good signals from radiation related to a rare particle in physics experiments and related to the tumor markers (511 keV photons) for medical imaging applications, at the lowest cost per valid signal captured compared to other approaches”.

My 3D-CBS (3-D Complete Body Screening) based on the 3D-Flow (see trifold goo.gl/YcAJDy”, and overview at “goo.gl/JMKyek”) is hundreds of times more efficient than the current over 10,000 PET devices. The 3D-Flow invention is technology-independent and can migrate to the most cost-effective technology. Both inventions 3D-Flow OPRA (Object Pattern Recognition Algorithm) and 3D-CBS have been proven feasible with current technology by 59 quotes from reputable industries.

  • The 3D-Flow OPRA invention can replace 4,000 CMS electronic data processing boards (goo.gl/mPHw5Y) in physics experiments with 9 electronic data processing boardsgoo.gl/OTkH4z” detailed at “goo.gl/w3XlZ1” while providing an enormous performance improvement at one thousandth the cost.
  • The 3D-CBS can claim to be the first true paradigm change in molecular imaging because it offers at once the three advantages of a) an effective early detection of diseases at a highly curable stage, improved diagnosis, prognosis and monitoring treatments effectively, b) a radiation dose that is 1% of current PET and c) a 4-minute, very low examination cost that will cover all organs of the body. Therefore, individual screening on specific parts of the body, such as mammograms, PAP-tests, colonoscopies and PSA, will not be necessary. (See also the comparison at “goo.gl/tmTZ9O” of the 3D-CBS goo.gl/6DS5oywith the “Explorer Project”: “goo.gl/Tl95NN” or at “goo.gl/ovMZ5j”, funded by NIH for $15.5 million although less efficient, without the ability to save many lives and is more than ten times as expensive as the 3D-CBS). The 3D-CBS invention can reduce cancer deaths by over 50% through an effective early detection while reducing healthcare costs. This page with hyperlinks is available at: goo.gl/9KzNJ6

Leave a Reply

Your email address will not be published. Required fields are marked *



Site Overview
Please visit our
Site Overview for help in navigating the site.
Subscribe to our Newsletter

Upcoming Events
October 2020
Monday Tuesday Wednesday Thursday Friday Saturday Sunday
September 28, 2020 September 29, 2020 September 30, 2020 October 1, 2020 October 2, 2020 October 3, 2020 October 4, 2020
October 5, 2020 October 6, 2020 October 7, 2020 October 8, 2020 October 9, 2020 October 10, 2020 October 11, 2020
October 12, 2020 October 13, 2020 October 14, 2020 October 15, 2020 October 16, 2020 October 17, 2020 October 18, 2020
October 19, 2020 October 20, 2020 October 21, 2020 October 22, 2020 October 23, 2020 October 24, 2020 October 25, 2020
October 26, 2020 October 27, 2020 October 28, 2020 October 29, 2020 October 30, 2020 October 31, 2020 November 1, 2020